Nektar Therapeutics
NKTR
#4234
Rank
A$3.87 B
Marketcap
A$116.77
Share price
-0.73%
Change (1 day)
554.22%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): A-$6.70

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is A-$5.94. In 2024 the company made an earnings per share (EPS) of A-$4.91 an increase over its 2023 EPS that were of A-$30.74.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$6.7036.39%
2024A-$4.91-84.02%
2023A-$30.74-25.89%
2022A-$41.47-31.12%
2021A-$60.2114.86%
2020A-$52.42-1.19%
2019A-$53.05-163.96%
2018A$82.95-725.4%
2017A-$13.26-42.73%
2016A-$23.1683.33%
2015A-$12.6339.53%
2014A-$9.05-69.29%
2013A-$29.47-6.67%
2012A-$31.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$15.63-363.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.91-132.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.11-438.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A-$2.60-56.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.26-272.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$8.32-240.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
A$0.09824-101.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
A$2.91-148.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland